PRTA Prothena Corporation plc
Healthcare$10.06+2.34%ClosedMarket Cap: $526.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.69
P/S
8.88
EV/EBITDA
-2.36
DCF Value
$3.52
FCF Yield
-15.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.8%
Operating Margin
-217.9%
Net Margin
-260.9%
ROE
-49.9%
ROA
-43.2%
ROIC
-39.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $51.1M | 98.2% | $25.8M | $32.7M | $— | — |
| Q4 null | $21.0K | -4385.7% | $-27.2M | $-21.6M | $— | — |
| FY null | $9.7M | 61.8% | $-184.6M | $-244.1M | $— | — |
| Q3 null | $2.4M | -1098.3% | $-40.2M | $-36.5M | $— | — |
| Q2 null | $4.4M | 100.0% | $-84.6M | $-125.8M | $— | — |
| Q1 null | $2.8M | 100.0% | $-65.6M | $-60.2M | $— | — |
| Q4 null | $2.1M | 100.0% | $-64.9M | $-58.0M | $— | — |
| FY null | $135.2M | 100.0% | $-154.6M | $-122.3M | $— | — |
| Q3 null | $970.0K | 100.0% | $-66.5M | $-59.0M | $— | — |
| Q2 null | $132.0M | 100.0% | $58.4M | $66.9M | $— | — |
| Q1 null | $50.0K | 100.0% | $-81.5M | $-72.2M | $— | — |
| Q4 2023 | $316.0K | -19485.8% | $-78.5M | $-67.5M | $-1.26 | — |